NXGN Nextgen Healthcare Inc

Price (delayed)

$15.95

Market cap

$1.07B

P/E Ratio

79.75

Dividend/share

N/A

EPS

$0.2

Enterprise value

$1.03B

Highlights
Nextgen Healthcare's EPS has surged by 150% YoY and by 43% QoQ
NXGN's net income has soared by 143% YoY and by 39% QoQ
The quick ratio has plunged by 54% YoY but it has grown by 8% from the previous quarter

Key stats

What are the main financial stats of NXGN
Market
Shares outstanding
67.27M
Market cap
$1.07B
Enterprise value
$1.03B
Valuations
Price to earnings (P/E)
79.75
Price to book (P/B)
2.44
Price to sales (P/S)
1.87
EV/EBIT
70.56
EV/EBITDA
15.03
EV/Sales
1.8
Earnings
Revenue
$572.03M
EBIT
$14.62M
EBITDA
$68.63M
Free cash flow
$52.51M
Per share
EPS
$0.2
Free cash flow per share
$0.78
Book value per share
$6.54
Revenue per share
$8.52
TBVPS
$4.21
Balance sheet
Total assets
$624.56M
Total liabilities
$186M
Debt
$28.43M
Equity
$438.57M
Working capital
$39.13M
Liquidity
Debt to equity
0.06
Current ratio
1.25
Quick ratio
0.93
Net debt/EBITDA
-0.61
Margins
EBITDA margin
12%
Gross margin
50.7%
Net margin
2.3%
Operating margin
2.6%
Efficiency
Return on assets
2%
Return on equity
3.1%
Return on invested capital
12.5%
Return on capital employed
3.1%
Return on sales
2.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NXGN stock price

How has the Nextgen Healthcare stock price performed over time
Intraday
0.38%
1 week
-2.09%
1 month
-3.45%
1 year
11.85%
YTD
-12.55%
QTD
-3.86%

Financial performance

How have Nextgen Healthcare's revenue and profit performed over time
Revenue
$572.03M
Gross profit
$290.23M
Operating income
$14.67M
Net income
$13.19M
Gross margin
50.7%
Net margin
2.3%
NXGN's operating income has surged by 162% year-on-year and by 14% since the previous quarter
The operating margin has soared by 160% YoY and by 13% QoQ
NXGN's net income has soared by 143% YoY and by 39% QoQ
The net margin has soared by 130% YoY and by 35% from the previous quarter

Growth

What is Nextgen Healthcare's growth rate over time

Valuation

What is Nextgen Healthcare stock price valuation
P/E
79.75
P/B
2.44
P/S
1.87
EV/EBIT
70.56
EV/EBITDA
15.03
EV/Sales
1.8
Nextgen Healthcare's EPS has surged by 150% YoY and by 43% QoQ
The price to earnings (P/E) is 49% less than the 5-year quarterly average of 155.2 and 36% less than the last 4 quarters average of 125.0
The P/B is 13% below the 5-year quarterly average of 2.8 and 7% below the last 4 quarters average of 2.6
NXGN's equity is up by 9% year-on-year
The stock's price to sales (P/S) is 7% less than its last 4 quarters average of 2.0
The revenue has increased by 6% YoY and by 2.7% from the previous quarter

Efficiency

How efficient is Nextgen Healthcare business performance
NXGN's ROA has soared by 150% YoY and by 43% from the previous quarter
Nextgen Healthcare's ROE has soared by 121% YoY and by 35% from the previous quarter
Nextgen Healthcare's return on sales has surged by 100% YoY and by 13% QoQ
The return on invested capital has surged by 67% since the previous quarter

Dividends

What is NXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NXGN.

Financial health

How did Nextgen Healthcare financials performed over time
The quick ratio has plunged by 54% YoY but it has grown by 8% from the previous quarter
The total liabilities has decreased by 49% YoY and by 13% QoQ
The debt is 94% less than the equity
The debt to equity has plunged by 89% YoY and by 14% from the previous quarter
The debt has plunged by 87% YoY and by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.